Stephanie Santos

Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?

C. Howlett, B. Sadikovic, Hanxin Lin, 2021, International journal of laboratory hematology.

Implementation of an NGS‐based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies

H. Feilotter, Ping Yang, P. Ainsworth, 2019, European journal of haematology.

Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies

B. Sadikovic, L. Schenkel, Hanxin Lin, 2022, Molecular Diagnosis & Therapy.

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood

H. Feilotter, D. Demetrick, D. Grafodatskaya, 2021, JTO clinical and research reports.

Molecular profiling of solid tumors by next-generation sequencing: an experience from a clinical laboratory

C. Howlett, M. Cecchini, S. Welch, 2023, Frontiers in oncology.

Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies

B. Sadikovic, L. Schenkel, Hanxin Lin, 2022, Molecular Diagnosis & Therapy.

Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome

Ping Yang, C. Howlett, B. Sadikovic, 2020, British journal of haematology.